Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NeuroBo Pharmaceuticals Inc
NRBO
Healthcare
Biotechnology
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. It is developing DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Type 2 Diabetes Mellitus (T2DM), and is developing DA-1726 for the treatment of obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with...
development optionality as a standalone and/or combination therapy for both MASH and T2DM. Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide, and peptide YY. DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is to be administered once weekly subcutaneously. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NRBO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(170)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 13, 2024 7:45pm
NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part
Breaking News: $NRBO NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of ObesityNeuroBo Pharmaceuticals Completes
...more
(170)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jun 24, 2024 6:00pm
NeuroBo Pharmaceuticals Announces up to $70 Million Concurre
News; $NRBO NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNeuroBo Pharmaceuticals Announces up
...more
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 13, 2024 9:03am
NRBO.....low vol on NR this a.m
On watch
(170)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 01, 2024 12:45pm
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
BREAKING NEWS: $NRBO Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations | BenzingaU.S. stocks traded higher midway through trading, with the S@P 500 gaining around 0.5% on Thursday.The Dow
...more
(170)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 01, 2024 10:00am
NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a
News; $NRBO NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of ObesityNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a
...more
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 23, 2022 12:57pm
NRBO .... Heads up ; )
A break of $1.65 could be meaningful
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 23, 2022 12:39pm
NRBO...... On watch
Nice volume .....it just needs some Price action Coin toss
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 10, 2022 11:44am
NRBO ..... BTFD anyone ?
Or am I the only one with the cajoles ??? LMFAO
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 09, 2022 1:38pm
NRBO ..... Well Folks... Guess what?
I'm f'king right again .......LMFAO And all u peeps can't even take 2 f'king seconds to like my posts What ever !
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 09, 2022 9:20am
NRBO ....early a.m runner in the pre market open ; )
Traded as high as $1.80 Lets see if this turns out to be a major move to fill that 2nd gap I previously mentioned or its just another typical NASDAQ open by "Burning Retail traders" Maybe
...more
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Nov 08, 2022 5:18pm
RE:NRBO ..... There is now 2 "Gaps" above this level.....
All this price action in After Hours trading is just the 1st "Gap Target"...lokking forward to see this trading in the 2nd target.....it starts a $1.61 Cheers !
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 08, 2022 5:10pm
NRBO..... $1.48 now in AH trading ; )
Mr Maggot and I are like ..... friends ; )
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 08, 2022 4:30pm
NRBO..... Take a f'king look at this in AH trading
I'm really starting to wonder about this B.S I tend to think that regular hours trading is all about "burning retail" watch them squirm while Mr. Maggot puts the screws to them
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 08, 2022 4:06pm
New Press Release - NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT
CLOSES EXCLUSIVE LICENSE OF ASSETS FROM DONG-ABOSTON, Nov. 8, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced the closing of an underwritten...
read article.
(67)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 08, 2022 12:26pm
NRBO ..... Grinch is stealing Xmas now ; )
Maddapakka
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed